view article
Figure 2
Determination of the Cys528 DeStreak modification of human CRM1 with 2-mercaptoethanol (BME) using mass-spectrometric analysis. (a) List of possible fragment ions of the Cys528–BME-containing peptide [DLLGLC(+75.99)EQK] with detected y ions in blue and b ions in red. (b) Representative fragmentation spectrum (1 of 15) of the respective precursor ion with an m/z of 547.765. RT, retention time.

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X
Volume 77| Part 3| March 2021| Pages 70-78
https://doi.org/10.1107/S2053230X2100203X
Follow Acta Cryst. F
Sign up for e-alerts
E-alerts
Follow Acta Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS